CClinicalTrials.gg
CompletedNCT04515654Updated Aug 17, 2020

Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre

An interventional study of IDEAS (Identity Evolution and Sharing) Performance in Transgenderism and Stigma, Social, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-17.

Sponsored by Indiana University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2019, registered May 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population.

Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar Participants: 42 audience members and 6 trans interviewees Intervention: Virtual, narrative-informed play reading and moderated discussion about gender diversity and affirmative care Outcomes and Measures: The valid and reliable Acceptance and Action Questionnaire - Stigma (AAQ-S) assesses stigma beliefs; An open-ended qualitative question assesses trans interviewees' experiences

02

Conditions studied

  • Transgenderism
  • Stigma, Social

Keywords

  • gender
  • drama
  • disability studies
  • qualitative
  • stigma
  • affirmative care
  • minority health
03

In context

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age 18 or older

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Audience participants

    Community members viewed the performance (intervention) and completed pre/post stigma questionnaire

    Other: IDEAS (Identity Evolution and Sharing) Performance

Interventions

  • OtherIDEAS (Identity Evolution and Sharing) Performance

    60 minute webinar depicting first-hand stories of transgender and gender non-conforming individuals followed by expert panel/talk-back

    Also known as: Performance

06

What researchers measure

Primary outcomes

  1. Acceptance and Action Questionnaire-stigma

    The Acceptance and Action Questionnaire - Stigma (AAQ-S) survey

    Time frame: 1 week

07

Study locations

1 site
  • Indiana University Purdue University Indianapolis
    Indianapolis, Indiana 46202, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04515654
Lead sponsor
Indiana University
Responsible party
Sally Wasmuth (Asistant Professor OT, Indiana University) — Principal investigator
First posted
Aug 17, 2020
Start date
Jan 15, 2019
Primary completion
May 15, 2020
Completion
May 15, 2020
Last update
Aug 17, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion